Company Overview and News

 
NZ shares fall most across Asia; Z Energy still under pressure

3h nzherald.co.nz
New Zealand shares fell the most across Asia as Z Energy led the market lower for another day amid rising oil prices, growing competition and the threat of increased regulation.
CEN PGC AIR FCREY ZNRGF NZTCF RYM ACKDF ANZFY AUKNY AIZ COENF SKT ZNZ SYKWF CEN SKKTY AIA FBU RHCGF SPKKY NZTCY EBOSY SPK ZEL FRCEF EBO COENY KWIPF EBOSF AIA FBU ANZLY RYHTY ANZFF MEZ EBO

 
Sneak peak at Air New Zealand's new safety video featuring Julian Dennison, Kings, Theia, Randa

3h nzherald.co.nz
Air New Zealand has released a peek of its new safety video featuring hundreds of local performers ranging from the Mosgiel Brass Band to transgender rapper Randa.
ANZLY AIR ANZFF ANZFY AIZ

 
Business advisory body experts named

16h radionz.co.nz
The newly-announced members of the Business Advisory Council will provide "free and frank" advice to the government, Prime Minister Jacinda Ardern says.
ANZLY AIR ANZFF ANZFY AIZ

 
Revealed: How much NZ's top bosses are paid

16h nzherald.co.nz
Chief executives at New Zealand's biggest companies got a 2.2 per cent pay rise last year, taking their average earnings to $1,755,352 in the 2017 financial year.
AIA AIA ANZLY AIR ANZFF ANZFY ACKDF AUKNY MEZ AIZ

 
Singapore Airlines' ultra long-haul flight: Is this the future?

16h nzherald.co.nz
Singapore Airlines' move to reclaim the crown for the world's longest flight has thrown the future of ultra-long haul travel into the spotlight. At the same time, it also highlights the different approaches airlines are taking.
C6L ANZLY AIR ANZFF SINGY ANZFY AIZ SINGF

 
Air NZ on track to be 'the world's least unsustainable airline'

2018-10-16 nzherald.co.nz
Air New Zealand is on a credible journey to try and be "the world's least unsustainable airline", the chair of the national carrier's Sustainability Advisory Panel, Jonathon Porritt, told an assembly of senior politicians, airline stakeholders and journalists in Wellington.
ANZLY AIR ANZFF ANZFY AIZ

 
Air New Zealand Partners With Autonomous Air Taxi Developer

2018-10-16 aviationweek
Air New Zealand aims to help develop the autonomous air taxi concept by partnering with a company testing such an aircraft in New Zealand. The airline and Zephyr Airworks have signed an agreement to “work collaboratively on bringing the world's first autonomous electric air taxi service to market in New Zealand,” the companies said Oct. 16. Zephyr Airworks was established in New Zealand in 2016 by California-based Kitty Hawk, which developed the Cora electric air taxi .
ANZLY AIR ANZFF ANZFY AIZ

 
Air NZ and Google founder set to bring self-driving air taxis to NZ

2018-10-15 nzherald.co.nz
Air New Zealand and Zephyr Airworks today announced they have signed an agreement to work collaboratively on bringing the world's first autonomous electric air taxi service to market in New Zealand.
ANZLY AIR ANZFF ANZFY AIZ

2
Encouraging September Traffic Results From Southwest Ahead Of Third Quarter Earnings

2018-10-15 seekingalpha
Southwest Airlines reported year-over-year September 2018 traffic with revenue passenger miles and available seat miles increasing 5.3% and 6.8%, respectively.
JAPSY C6L AIR HA JBLU SINGY ANZFY AIZ ANZLY BOE ANZFF BA DAL SINGF

15
Air New Zealand's secret cabin revamp turns to Nasa for seat ideas

2018-10-14 nzherald.co.nz
Air New Zealand is looking at the zero gravity position of astronauts as a way of seating its long-haul passengers more comfortably as it continues secret work on its next-generation cabins.
C6L GEC GE ANZLY AIR GNE ANZFF SINGY ANZFY AIZ SINGF

 
Kerre McIvor: I can't get on board with the outrage about the Koru Lounge

2018-10-13 nzherald.co.nz
I'm not at Gold Elite level but I've certainly spent more time in the air than I ever would have imagined as a young girl growing up in small-town New Zealand.
AIA AIA ANZLY AIR ANZFF ANZFY ACKDF AUKNY AIZ

 
Fran O'Sullivan: Why Jacinda Ardern has missed her Boadicea moment

2018-10-12 nzherald.co.nz
With Dame Jenny Shipley, her Boadicea moment was her ousting of Jim Bolger as Prime Minister in a backroom coup and the sacking of Winston Peters as Treasurer.
ANZLY AIR ANZFF ANZFY AIZ

 
NZ shares snap losing streak as A2 bounces back

2018-10-12 nzherald.co.nz
New Zealand shares ended a nine-day losing streak, with A2 Milk Co and blue-chip stocks such as Spark New Zealand, Mercury NZ and Auckland International Airport driving the recovery.
AIA AIR SPKKY NZTCY SPK NZTCF ACKDF ANZFY AUKNY AIZ KWIPF AIA ANZLY ANZFF MEZ PFGTF

 
Deal values Kiwi Tim Brown's woollen sneaker company at $2b

2018-10-11 nzherald.co.nz
Allbirds, the trendy woollen sneaker-maker co-founded by New Zealander Tim Brown, has raised US$50m ($72.5m) at post-money valuation of US$1.4 billion ($2.03b).
ANZLY AIR ANZFF ANZFY AIZ

 
Canadian Startup Jetlines’ A320 Deliveries Set For Q2 2019

2018-10-11 aviationweek
Canadian ultra-LCC Jetlines said delivery of its first two aircraft is on schedule for “early” second quarter 2019 following its second set of advance lease payments to lessor AerCap. The two Airbus A320s, MSNs 2594 and 2663, are currently with Air New Zealand, but will soon transition out of the carrier’s fleet for re-configuration. Jetlines will configure the aircraft with 180 seats, and will use Acro Aircraft Seating’s Series 3 ST seats.
ANZLY AIR ANZFF ANZFY AIZ

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...